Inherited thrombophilia

Vascular Medicine

Volumn 9, Issue 3, 2004, Pages 219-221

  Walker, Isobel D ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8A; PROTEIN C; PROTEIN S; THROMBIN;

ACTIVATED PROTEIN C RESISTANCE; AMINO ACID SUBSTITUTION; ARTERY DISEASE; ARTERY RECONSTRUCTION; ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; GENETIC DISORDER; GENETIC POLYMORPHISM; GRAFT OCCLUSION; HUMAN; HYPERCOAGULABILITY; PATHOGENESIS; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; TREATMENT FAILURE; VENOUS THROMBOEMBOLISM;

HUMANS; LOWER EXTREMITY; PERIPHERAL VASCULAR DISEASES; THROMBOPHILIA;

EID: 12344291898     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x04vm556xx     Document Type: Article

References (23)

1. Fowkes FGR, Lowe GDO, Housley E et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342: 84-86.
2. Tait RC, Walker ID, Perry DJ et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-12.
3. Tait RC, Walker ID, Reitsma PH et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73 87-93.
4. Dykes AC, Walker ID, McMahon AD, Islam SIAM, Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-41.
5. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
6. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-34.
7. Camerlingo M, Finazzi G, Casto L, Laffranchi C, Barbui T, Mamoli A. Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adults. Neurology 1991; 41: 1371-73.
8. Grewal RP, Goldberg MA. Stroke in protein C deficiency. Am J Med 1990; 89: 538-39.
9. Kohler J, Kasper J, Witt I, von Reutern G-M. Ischemic stroke due to protein C deficiency. Stroke 1990; 21: 1077-80.
10. Munts AG, van Genderen PJJ, Dippel DWJ, van Kooten F, Koudstaal PJ. Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 1998; 245: 21-25.
11. Doggen CJM, Cats VM, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210 A. Circulation 1998; 97: 1037-41.
12. Donaldson MC, Weinberg DS, Belkin M, Whittemore AD, Mannick JA. Screening for hypercoagulable states in vascular surgical practice: a preliminary study. J Vasc Surg 1990; 11: 825-31.
13. Ray SA, Rowley MR, Loh A et al. Hypercoagulable states in patients with leg ischaemia. Br J Surg 1994; 81: 811-14.
14. Valentine RJ, Kaplan HS, Green R et al. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg 1996; 23: 53-63.
15. Eldrup-Jorgensen J, Flanigan DP, Brace L et al. Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg 1989; 9: 334-41.
16. Allaart CF, Aronson DC, Ruys T et al. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1990; 64: 206-10.
17. Sampram ESK, Lindblad B, Dahlback B. Activated protein C resistance in patients with peripheral vascular disease. J Vasc Surg 1998; 28: 624-29.
18. Foley PWX, Irvine CD, Standen GR et al. Activated protein C resistance, factor V Leiden and peripheral and vascular disease. Cardiovasc Surg 1997; 5: 157-60.
19. Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430-33.
20. Ray SA, Rowley MR, Bevan DH, Taylor RS, Dormandy JA. Hypercoagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg 1997; 13: 363-70.
21. Arfvidsson B, Lundgren F, Drott C, Schersten T, Lundholm K. Influence of coumarin treatment of patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg 1990; 159 556-60.
22. Kretschmer G, Herbst F, Prager M et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 1992; 127: 1112-15.
23. Tangelder MJD, Algra A, Lawson JA et al. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet 2000; 355: 346-51.